Navigation Links
Strategic Product Deployment Announcement: Clotamin
Date:4/13/2012

BEVERLY HILLS, Calif., April 13, 2012 /PRNewswire/ -- AATAC, AACSA, and SKYROCK retailers can expect to start seeing Clotamin appear in their locations for sale to the general public. A marketing and distribution agreement executed earlier this month with these groups allows retailers to participate in the resale of this product at various locations. Clotamin is anticipated to share premium counter top space alongside such products as 5-Hour Energy, Wrigley's Gum, Hershey's, and other industry specific names. Such influence over the retail industry has allowed companies to expose their product lines to over 1,000 customers a day in hard to reach areas.

Many convenience stores, small pharmacies, and ethnic grocery stores are located in areas that are highly neighborhood-centric. These are also the same areas that many popular and larger chains do not have a presence and makes it difficult for consumers in these areas to have easy access to breakthrough products such as Clotamin. Through this strategic deployment partnership, these associations look to be able to make this product available for the target consumer on a very local level. These combined locations touch 1 out of 3 Americans every single day. In 2011, 1 out of every 25 dollars spent nationwide was spent within these locations. This all adds up to giving companies and products a reach that was unobtainable in the past.

Clotamin is a product produced and distributed by Healthcare Distribution Specialists, LLC (HDS), a wholly owned subsidiary of Sunpeaks Ventures, Inc. who is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions. Sunpeaks Ventures also trades publicly under the OTCBB: SNPK ; PINKSHEETS: SNPK. For more information on Sunpeaks Ventures, Inc. visit them at www.sunpeaksventures.com.

"Early tracking and estimates show that Clotamin has the ability to be a breakout product in our retail channel and we look forward to seeing what this could mean in additional revenue to our retailers and added benefit for our consumers," said Paul Rock BOD TRUSTEE of AACSA PARTNERS and speaker for the AATAC council.

With the combined reach and anticipated growth of such products, the associations aim to take such products out to over 200,000 retail business locations across the USA.

"While many products are born and hatched in different industries, this is where they come to grow up and stretch their wings over the US population," stated Philipp Gruendler Vice President of SKYROCK Venture's corporate development program.

For more information, visit www.AATAC.co or call 888-662-7780.


'/>"/>
SOURCE AATAC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
3. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
4. Replidyne Provides Strategic Update
5. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
6. TorreyPines Therapeutics Announces Strategic Plan with Focus on Clinical Development Activities to Maximize Value of Versatile Lead Compounds
7. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
8. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
9. Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand
10. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
11. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
Breaking Medicine News(10 mins):